Summit Trail Advisors, LLC Alaunos Therapeutics, Inc. Transaction History

Summit Trail Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	BUY	$0.43 - $0.65 $10,912 - $16,495	25,378 New	25,378 $12,000
Q2 2022 Aug 09, 2022	SELL	$0.41 - $1.24 $976 - $2,953	-2,382 Reduced 8.58%	25,378 $31,000
Q3 2021 Nov 16, 2021	BUY	$1.44 - $2.73 $39,974 - $75,784	27,760 New	27,760 $51,000
Q1 2019 May 16, 2019	SELL	$2.0 - $4.4 $55,520 - $122,144	-27,760 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$3.02 - $4.94 $129 - $212	-43 Reduced 0.15%	27,760 $84,000
Q1 2018 May 22, 2018	SELL	$3.46 - $5.14 $337,657 - $501,607	-97,589 Reduced 77.83%	27,803 $125,000
Q1 2018 May 21, 2018	BUY	$3.46 - $5.14 $337,806 - $501,828	97,632 Added 351.7%	125,392 $125,000
Q4 2017 Feb 14, 2018	BUY	$4.0 - $6.54 $111,040 - $181,550	27,760	27,760 $128,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit Trail Advisors, LLC with notifications on news.